Droplet-born air blowing: Novel dissolving microneedle fabrication

Jung Dong Kim, Miroo Kim, Huisuk Yang, Kwang Lee, Hyungil Jung

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The microneedle-mediated drug delivery system has been developed to provide painless self-administration of drugs in a patient-friendly manner. Current dissolving microneedle fabrication methods, however, require harsh conditions for biological drugs and also have problems standardizing the drug dose. Here, we suggested the droplet-born air blowing (DAB) method, which provides gentle (4-25°C) and fast (≤10 min) microneedle fabrication conditions without drug loss. The amount of drug in the microneedle can be controlled by the pressure and time of droplet dispenser and the air blowing shapes this droplet to the microneedle, providing a force sufficient to penetrate skin. Also, the introduction of a base structure of two layered DAB-microneedle could provide complete drug delivery without wasting of drug. The DAB-based insulin loaded microneedle shows similar bioavailability (96.6 ± 2.4%) and down regulation of glucose level compared with subcutaneous injection. We anticipate that DAB described herein will be suitable to design dissolving microneedles for use in biological drug delivery to patients.

Original languageEnglish
Pages (from-to)430-436
Number of pages7
JournalJournal of Controlled Release
Volume170
Issue number3
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Air
Pharmaceutical Preparations
Self Administration
Subcutaneous Injections
Drug Delivery Systems
Biological Availability
Down-Regulation
Insulin
Pressure
Glucose
Skin

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Kim, Jung Dong ; Kim, Miroo ; Yang, Huisuk ; Lee, Kwang ; Jung, Hyungil. / Droplet-born air blowing : Novel dissolving microneedle fabrication. In: Journal of Controlled Release. 2013 ; Vol. 170, No. 3. pp. 430-436.
@article{ef8593a0a3d740bd8560c3ab2e9ac998,
title = "Droplet-born air blowing: Novel dissolving microneedle fabrication",
abstract = "The microneedle-mediated drug delivery system has been developed to provide painless self-administration of drugs in a patient-friendly manner. Current dissolving microneedle fabrication methods, however, require harsh conditions for biological drugs and also have problems standardizing the drug dose. Here, we suggested the droplet-born air blowing (DAB) method, which provides gentle (4-25°C) and fast (≤10 min) microneedle fabrication conditions without drug loss. The amount of drug in the microneedle can be controlled by the pressure and time of droplet dispenser and the air blowing shapes this droplet to the microneedle, providing a force sufficient to penetrate skin. Also, the introduction of a base structure of two layered DAB-microneedle could provide complete drug delivery without wasting of drug. The DAB-based insulin loaded microneedle shows similar bioavailability (96.6 ± 2.4{\%}) and down regulation of glucose level compared with subcutaneous injection. We anticipate that DAB described herein will be suitable to design dissolving microneedles for use in biological drug delivery to patients.",
author = "Kim, {Jung Dong} and Miroo Kim and Huisuk Yang and Kwang Lee and Hyungil Jung",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.jconrel.2013.05.026",
language = "English",
volume = "170",
pages = "430--436",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

Droplet-born air blowing : Novel dissolving microneedle fabrication. / Kim, Jung Dong; Kim, Miroo; Yang, Huisuk; Lee, Kwang; Jung, Hyungil.

In: Journal of Controlled Release, Vol. 170, No. 3, 01.01.2013, p. 430-436.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Droplet-born air blowing

T2 - Novel dissolving microneedle fabrication

AU - Kim, Jung Dong

AU - Kim, Miroo

AU - Yang, Huisuk

AU - Lee, Kwang

AU - Jung, Hyungil

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The microneedle-mediated drug delivery system has been developed to provide painless self-administration of drugs in a patient-friendly manner. Current dissolving microneedle fabrication methods, however, require harsh conditions for biological drugs and also have problems standardizing the drug dose. Here, we suggested the droplet-born air blowing (DAB) method, which provides gentle (4-25°C) and fast (≤10 min) microneedle fabrication conditions without drug loss. The amount of drug in the microneedle can be controlled by the pressure and time of droplet dispenser and the air blowing shapes this droplet to the microneedle, providing a force sufficient to penetrate skin. Also, the introduction of a base structure of two layered DAB-microneedle could provide complete drug delivery without wasting of drug. The DAB-based insulin loaded microneedle shows similar bioavailability (96.6 ± 2.4%) and down regulation of glucose level compared with subcutaneous injection. We anticipate that DAB described herein will be suitable to design dissolving microneedles for use in biological drug delivery to patients.

AB - The microneedle-mediated drug delivery system has been developed to provide painless self-administration of drugs in a patient-friendly manner. Current dissolving microneedle fabrication methods, however, require harsh conditions for biological drugs and also have problems standardizing the drug dose. Here, we suggested the droplet-born air blowing (DAB) method, which provides gentle (4-25°C) and fast (≤10 min) microneedle fabrication conditions without drug loss. The amount of drug in the microneedle can be controlled by the pressure and time of droplet dispenser and the air blowing shapes this droplet to the microneedle, providing a force sufficient to penetrate skin. Also, the introduction of a base structure of two layered DAB-microneedle could provide complete drug delivery without wasting of drug. The DAB-based insulin loaded microneedle shows similar bioavailability (96.6 ± 2.4%) and down regulation of glucose level compared with subcutaneous injection. We anticipate that DAB described herein will be suitable to design dissolving microneedles for use in biological drug delivery to patients.

UR - http://www.scopus.com/inward/record.url?scp=84885158039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885158039&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2013.05.026

DO - 10.1016/j.jconrel.2013.05.026

M3 - Article

C2 - 23742882

AN - SCOPUS:84885158039

VL - 170

SP - 430

EP - 436

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -